# FDA recall D-1104-2023

> **Inmar Supply Chain Solutions, LLC** · Class II · drug recall initiated 2023-08-14.

## Product

All Over-The-Counter (OTC) drug products warehoused, salvaged, and sold by Inmar.

## Reason for recall

CGMP Deviations: Potential exposure to rodents and rodent activity in the distribution center. Also, due to unusually hot weather, FDA Recalled Products may have been subjected to temperatures in excess of storage condition instructions on product labeling.

## Distribution

Separate Distribution List (salvage buyers) provided by Inmar and will be uploaded. Final customer distribution unknown.

## Key facts

- **Recall number:** D-1104-2023
- **Recalling firm:** Inmar Supply Chain Solutions, LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Ongoing
- **Initiation date:** 2023-08-14
- **Report date:** 2023-08-30

- **Voluntary/Mandated:** N/A
- **Location:** Arlington, TX, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1104-2023

## Citation

> AI Analytics. FDA recall D-1104-2023. Retrieved 2026-07-20 from https://api.ai-analytics.org/recall/D-1104-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*